Nitric oxide regulation system in degenerative lumbar disease

Kurume Medical Journal

Volumn 52, Issue 1-2, 2005, Pages 39-47

  Watanabe, Takuya ^a   Kato, Seiya ^a   Sato, Kimiaki ^a   Nagata, Kensei ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asymmetric dimethyl arginine (ADMA); Degenerative lumbar disease; Dimethylarginine dimethylaminohydrolase (DDAH); Inducible nitric oxide synthase (iNOS); Lumbar intervertebral disc herniation; Lumbar spinal canal stenosis; Nitric oxide (NO)

Indexed keywords

3 NITROTYROSINE; ARGININE; DIMETHYLARGININASE; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; AMIDASE; NOS2A PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOW BACK PAIN; LUMBAR DISK HERNIA; LUMBAR SPINAL CORD; MALE; MONONUCLEAR CELL; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SCORING SYSTEM; SPINAL CORD DISEASE; STENOSIS; AGE; INTERVERTEBRAL DISK HERNIA; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; VERTEBRAL CANAL STENOSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AMIDOHYDROLASES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; SPINAL STENOSIS;

EID: 24144481910     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.52.39     Document Type: Article

References (46)

1. Furchgott RF, and Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial muscle by acetylcholine. Nature 1980; 288:373-378.
2. Drapier JC, and Hibbs JB. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells - inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 1986; 78:790-797.
3. Palmer RMJ, Ferrige AG, and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
4. Palmer RMJ, Ashton DS, and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333:664-666.
5. Moncada S, and Higgs EA. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
6. Forstermann N, Closs EI, Pollock JS, Nakane M, Shwarz P et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions. Hypertension 1994; 23:1121-1131.
7. Farrell AJ, Blake DR, Palmer RM, and Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-1222.
8. Benzing WC, and Mufson EJ. Increased number of NADPH-δ-positive neurons within the substantia innominata in Alzheimer's disease. Brain Res 1995; 30:351-355.
9. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR et al. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 1998; 18:8126-8132.
10. Smith MA, Harris RPL, Sayre LM, Beckman JS, and Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997; 17:2653-2657.
11. Su JH, Deng G, and Cotman CW. Neuronal DNA damage precedes tangle formation and is associated with upregulation of nitrotyrosine in Alzheimer's disease brain. Brain Res 1997; 774:193-199.
12. Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki E et al. Alteration of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 1999; 269:52-54.
13. Asahara H, Yokoi I, Tamada T, Kabuto H, Ogawa N et al. Increased cerebrospinal fluid nitrite and nitrate levels in patients with lumbar spondylosis. Res Commun Mol Pathol Pharmacol 1996; 91:77-83.
14. Kimura S, Watanabe K, Yajiri Y, Motegi T, Masuya Y et al. Cerebrospinal fluid nitric oxide metabolites in painful diseases. Neuroreport 1999; 10:275-279.
15. G-mono, di, trimethyllysine and glucosyl, galactosyl and galactosyl-δ-hydroxylysine from human urine. J Biol Chem 1970; 245:5751-5758.
16. Vallance P, Leone A, Calver A, Collier J, and Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992; 20:S60-S62.
17. Matsuoka H, Itoh S, Kimoto M, Kohno K, Tamai O et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 1997; 29:242-247.
18. Böger RH, Bode-Böger SM, Szuba A, Tsao P, Chan J et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98:1842-1847.
19. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 1999; 99:1141-1146.
20. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K et al. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997; 95:2068-2074.
21. Leiper J, and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 1999; 43:542-548.
22. G-dimethylarginine in rats. Arch Biochem Biophys 1987; 252:526-537.
23. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem 1989; 264:10205-10209.
24. MacAllister RJ, Pickling SA, Whitley GS, and Vallance P. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol 1994; 112:43-48.
25. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J Biochem Tokyo 1995; 117:237-238.
26. G-dimethylarginine dimethylaminohydrolase. Eur J Biochem 1998; 258:863-868.
27. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T et al. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999; 99:3092-3095.
28. Aoki T, Kato S, Sugita Y, Terasaki M, Miyagi N et al. Expression of inducible nitric oxide synthase and NG, NG-dimethylarginine dimethylaminohydrolase after experimental traumatic brain injury in rats. Adva Neurotrau Res 1998; 10:31-34.
29. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: Role of dimethylarginine dimethylaminohydrolase. Circ Res 2003; 92:226-233.
30. Böger RH, Sydow K, Borlak J, Thum T, Lenzen H et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells. Involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000; 87:99-105.
31. Vallance P, Leone A, Calver A, Collier J, and Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
32. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20:2032-2037.
33. MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russell R et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol 1996; 119:1533-1540.
34. Hasegawa K, Hirata Y, Morita T, and Kobayashi H. Stabilization effects of Graf ligamentoplasty. J Musculoskeletal Res 1999; 3:217-232.
35. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138.
36. Kimura S, Watanabe K, Yajiri Y, Motegi T, Masuya Y et al. Cerebrospinal fluid nitric oxide metabolites in painful diseases. Neuroreport 1999; 10:275-279.
37. Yamada K, Noda Y, Komori Y, Sugihara H, Hasegawa T et al. Reduction in the number of NADPH-diaphorase-positive cells in the cerebral cortex and striatum in aged rats. Neurosci Res 1996; 24:393-402.
38. Yamada K, Nishiwaki K, Hattori K, Senzaki K, Nagata M et al. No changes in cerebrospinal fluid levels of nitrite, nitrate and cyclic GMP with aging. Short communication. J Neural Transm 1997; 104:825-831.
39. Abe T, Tohgi H, Murata T, Isobe C, and Sato C. Reduction in asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in the cerebrospinal fluid during aging and in patients with Alzheimer's disease. Neurosci Lett 2001; 312:177-179.
40. Mulder C, Wahlund LO, Blomberg M, de long S, van Kamp GJ et al. Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid. J Neural Transm 2002; 109:1203-1208.
41. Yumite Y, Takeuchi K, Harada Y, Ogawa N, and Inoue H. Concentration of nitric oxide (NO) in spinal fluid of chronic spinal disease. Acta Med Okayama 2001; 55:219-228.
42. Kimura S, Watanabe K, Yajiri Y, Uchiyama S, Hasegawa K et al. Cerebrospinal fluid nitric oxide metabolites are novel predictors of pain relief in degenerative lumbar diseases. Pain 2001; 92:363-371.
43. Meller ST, and Gebhart GF. The role of nitric oxide in spinal nociceptive processing. In: Nitric oxide, roles in neuronal communication and neurotoxicity, eds. Takagi H, Toda N, and Hawkins RD, Japan Scientific Society Press, Tokyo and CRC Press, Boca Raton, Florida, pp115-125, 1994.
44. Kimura S, Yajiri Y, Uchiyama S, Takahashi HE, and Shibuki K. Nitric oxide release from substantia gelatinosa of the rat spinal cord in vitro. Neurosci Lett 1999; 275:199-202.
45. Ooi Y, Mita F, and Satoh Y. Myeloscopic study on lumbar spinal canal stenosis with special reference to intermittent claudication. Spine 1990; 15:544-549.
46. Takahashi K, Olmarker K, Holm S, Porter RW, and Rydevik B. Double-level cauda equina compression: An experimental study with continuous monitoring of intraneural blood flow in the porcine cauda equina. J Orthop Res 1993; 11:104-109.